Patoloxía Molecular das Doenzas Raras
PatMol-DR
Hospital Universitario de la Princesa
Madrid, EspañaPublicacións en colaboración con investigadores/as de Hospital Universitario de la Princesa (10)
2023
-
Cardiogenic shock code 2023. Expert document for a multidisciplinary organization that allows quality care
Revista Espanola de Cardiologia, Vol. 76, Núm. 4, pp. 261-269
-
The three-noes right-sided infective endocarditis: An unrecognized type of right-sided endocarditis
Medicine, Vol. 102, Núm. 29, pp. e34322
2022
-
Safety and efficacy of a cardiovascular polypill in people at high and very high risk without a previous cardiovascular event: the international VULCANO randomised clinical trial
BMC Cardiovascular Disorders, Vol. 22, Núm. 1
2020
-
Nutritional Risk and Mortality at One Year for Elderly Patients Hospitalized with Nonvalvular Atrial Fibrillation. NONAVASC Registry
Journal of Nutrition, Health and Aging
-
Reducing residual thrombotic risk in patients with peripheral artery disease: Impact of the COMPASS trial
Drugs in Context, Vol. 9
-
Residual risk reduction opportunities in patients with chronic coronary syndrome. Role of dual pathway inhibition
Expert Review of Clinical Pharmacology, Vol. 13, Núm. 7, pp. 695-706
2018
-
Influence of sex and pregnancy on survival in patients admitted with heart failure: Data from a prospective multicenter registry
Clinical Cardiology, Vol. 41, Núm. 7, pp. 924-930
-
Rivaroxaban: searching the integral vascular protection
Expert Review of Clinical Pharmacology, Vol. 11, Núm. 7, pp. 719-728
2015
-
Tratamiento antitrombótico en el paciente anciano con fibrilación auricular
Revista Clinica Espanola, Vol. 215, Núm. 3, pp. 171-181
2007
-
Prevalencia de enfermedad arterial periférica estimada mediante el índice tobillo-brazo en pacientes con síndrome metabólico. Estudio MERITO I
Revista Clinica Espanola, Vol. 207, Núm. 5, pp. 228-233